On Cancer

Filter by Tag

Pictured: Vincent Laudone and James Eastham

Perspective

When Do No Harm Means Do Nothing: Managing Risks

By James Eastham, MD and Vincent Laudone, MD
Friday, September 20, 2013

An earlier post about active surveillance as a management strategy for prostate cancer generated an engaged and meaningful discussion on this blog, especially about the risks of “doing nothing.” Here we take a closer look at the concept of risk.

Tags: Cancer Care; Treatment; Prostate Cancer

Cancer Guide

New Information about Multiple Myeloma Care at Memorial Sloan-Kettering

By Jim Stallard, MA, Writer/Editor | Friday, September 13, 2013

Memorial Sloan-Kettering specialists provide outstanding care for multiple myeloma and related plasma cell diseases.

Tags: Blood & Marrow Stem Cell Transplantation; Cancer Care; Multiple Myeloma

In the O.R.

Data on New Procedure to Remove Small Breast Cancers Shows Benefits to Patient Experience

By Media Staff | Tuesday, September 10, 2013

Memorial Sloan-Kettering clinicians report on a successful first year of using a new procedure to pinpoint and remove small breast cancers.

Tags: Cancer Care; Clinical Research; Medical Technology; Surgery; Breast Cancer

Pictured: Mark Kris, Andreas Rimner, Nabil Pierre Rizk & Max Gomez

Video

Watch Our Experts Discuss the Latest in Lung Cancer Management and Research

By Helen Garey, MPH | Tuesday, September 3, 2013

In a recent CancerSmart talk focused on lung cancer, three Memorial Sloan-Kettering experts described advances in diagnosis and treatment.

Tags: Cancer Care; CancerSmart; Screening; Treatment; Lung Cancer

Video

Meet Head and Neck Surgeon Ian Ganly

By Memorial Sloan-Kettering | Wednesday, August 28, 2013

Dr. Ganly explains that experts in all disciplines – including medical oncology, radiation oncology, and surgery – work together as a team to deliver treatments offering the best results possible for patients.

Tags: Cancer Care; Surgery; Treatment; Head & Neck Cancers

In the Clinic

Comparison of Drugs for Advanced Kidney Cancer Suggests Side Effects Are More Manageable with Newer Option

By Maureen Salamon, BA | Thursday, August 22, 2013

An international study led by Memorial Sloan-Kettering found that pazopanib (Votrient^®) controls cancer as effectively as sunitinib (Sutent^®) while improving patients’ quality of life.

Tags: Cancer Care; Research; Clinical Research; Drug Discovery; Targeted Therapy; Kidney Cancer

Cancer Guide

New Information about Cervical Cancer Screening and Treatment at Memorial Sloan-Kettering

By Andrea Peirce, BA, Writer/Editor | Friday, August 16, 2013

Memorial Sloan-Kettering uses a multidisciplinary approach to provide leading-edge care to women with cervical cancer.

Tags: Cancer Care; Prevention; Cervical Cancer; Screening; Treatment

Pictured: Vincent Laudone & James Eastham

Perspective

When “Do No Harm” Means “Do Nothing”

By James Eastham, MD and Vincent Laudone, MD
Wednesday, August 14, 2013

Active surveillance is the most appropriate management strategy for many men with prostate cancer, but often this option is never mentioned.

Tags: Cancer Care; Treatment; Prostate Cancer

In the Lab

Pattern in Lung Cancer Pathology May Predict Cancer Recurrence after Surgery

By Esther Napolitano, BS, Science Writer/Editor | Friday, August 9, 2013

A Memorial Sloan-Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

Tags: Cancer Care; Pathology; Research; Clinical Research; Surgery; Lung Cancer

In the Lab

Microbiome Studies May Benefit Cancer Patients

By Julie Grisham, MS, Science Writer/Editor | Wednesday, August 7, 2013

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

Tags: Blood & Marrow Stem Cell Transplantation; Cancer Care; Lab Research; Research; Infectious Diseases

Perspective

Making Clinical Trials More Efficient, Informative, and Effective

By Paul Sabbatini, MD, Deputy Physician-in-Chief for Clinical Research | Friday, July 26, 2013

The clinical trial remains our best tool to identify new therapies, but as with all tools, innovation is required if trials are to remain relevant.

Tags: Cancer Care; Research; Clinical Trials; Personalized Medicine; Drug Discovery

Ask the Expert

How Do I Decide Whether I Should Bank Cord Blood from My Newborn?

By Jim Stallard, MA, Writer/Editor | Wednesday, July 24, 2013

In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.

Tags: Blood & Marrow Stem Cell Transplantation; Cancer Care; Leukemias; Lymphomas

Honor

U.S. News & World Report Names Memorial Sloan-Kettering One of the Nation’s Best Hospitals for Cancer Care

By Media Staff | Tuesday, July 16, 2013

Memorial Sloan-Kettering is one of the nation’s top two hospitals for cancer care for the 24th year in a row and is also recognized for excellence in a range of medical specialties.

Tags: Cancer Care; Treatment

Pictured: Scott Armstrong, Michael Kuehn, Haijhua Chu, Monica Cusan & Andrei Kritsov

Profile

At Work: Pediatric Oncologist Scott Armstrong

By Esther Napolitano, BS, Science Writer/Editor | Friday, July 12, 2013

Scott Armstrong specializes in the treatment of leukemia in children. His research focuses on the disease in children and adults.

Tags: Research; Cancer Genetics; Targeted Therapy; Leukemias

In the News

Memorial Sloan-Kettering’s Collaboration with IBM Watson Featured on CBS This Morning

By Media Staff | Tuesday, July 9, 2013

Medical oncologist Mark G. Kris and one of his patients were interviewed for a CBS This Morning segment that describes how a Memorial Sloan-Kettering team trains the supercomputer IBM Watson to help doctors identify the best cancer management options for individual patients.

Tags: Cancer Care; Personalized Medicine; Medical Technology; Treatment